Brief: Harvard Bioscience Announces First Quarter 2022 Financial Results
04/05/2022 14:27
May 4 (Reuters) - Harvard Bioscience Inc HBIO.O :
* HARVARD BIOSCIENCE ANNOUNCES FIRST QUARTER 2022 FINANCIAL
RESULTS
* QTRLY REVENUES $28.8 MILLION VERSUS $27.0 MILLION
* QTRLY LOSS PER SHARE (GAAP) $0.17
* Q1 DILUTED ADJUSTED EARNINGS PER SHARE $0.04
* Q1 EARNINGS PER SHARE VIEW $0.05, REVENUE VIEW $28.8
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX47Ghnd
Further company coverage: HBIO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance